OTCMKTS:MRMD MariMed (MRMD) Stock Price, News & Analysis $0.16 0.00 (0.00%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$0.16▼$0.1750-Day Range$0.15▼$0.2852-Week Range$0.14▼$0.55Volume66,973 shsAverage Volume469,122 shsMarket Capitalization$61.85 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get MariMed alerts: Email Address Ad Golden CrestBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.>> Get Your FREE Wealth Protection Guide << About MariMed Stock (OTCMKTS:MRMD)MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.Read More MRMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MRMD Stock News HeadlinesAugust 26, 2024 | msn.comKey Cannabis Leaders Gather For Networking At Benzinga's Fall 2024 Conference: The Last Big Event Before The ElectionAugust 23, 2024 | uk.finance.yahoo.comMariMed Inc. (MRMD.CN)September 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. August 19, 2024 | globenewswire.comMariMed Announces Opening of Second Maryland DispensaryAugust 16, 2024 | benzinga.comVerano, Green Thumb & MariMed's Strong Q2: Unpacking The Cannabis Earnings SurgeAugust 14, 2024 | finanznachrichten.deCanadian Securities Exchange (CSE): Canadian Securities Exchange Reports July 2024 Performance FiguresAugust 14, 2024 | msn.comCanadian Securities Exchange Reports July 2024 Performance FiguresAugust 14, 2024 | proactiveinvestors.comMariMed succeeds with growth strategy prioritizing conservatism over quick winsSeptember 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. August 12, 2024 | msn.comCannabis Rescheduling Likely 'In The Next 12 Months,' Says MariMed CEO As Company Invests In Key MarketsAugust 8, 2024 | markets.businessinsider.comMRMD Stock Earnings: MariMed Beats Revenue for Q2 2024August 7, 2024 | globenewswire.comMariMed Reports Second Quarter 2024 EarningsAugust 7, 2024 | globenewswire.comMariMed Announces Appointment of Mario Pinho as Chief Financial OfficerAugust 6, 2024 | msn.comThe King Of Ohio's Recreational Cannabis Market? Here's Why Investors Should Follow This Weed StockJuly 22, 2024 | globenewswire.comMariMed Commences Operations In Newly Expanded Area of Maryland Cultivation FacilityJuly 9, 2024 | globenewswire.comMariMed Announces Second Quarter 2024 Earnings DateJuly 2, 2024 | globenewswire.comMariMed Announces Approval of Adult-Use Sales At Panacea Wellness Dispensary in Quincy, Massachusetts and Updates for Ohio and MarylandJuly 2, 2024 | globenewswire.comMariMed Closes Acquisition of Second Maryland DispensarySee More Headlines Receive MRMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2021Today9/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:MRMD CUSIPN/A CIK1522767 Webmarimedadvisors.com Phone(617) 795-5140FaxN/AEmployees260Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,030,000.00 Net Margins-10.97% Pretax Margin-5.28% Return on Equity-2.75% Return on Assets-1.06% Debt Debt-to-Equity Ratio1.01 Current Ratio1.55 Quick Ratio0.73 Sales & Book Value Annual Sales$148.60 million Price / Sales0.42 Cash Flow$0.03 per share Price / Cash Flow5.59 Book Value$0.19 per share Price / Book0.86Miscellaneous Outstanding Shares379,671,000Free Float301,649,000Market Cap$61.85 million OptionableNot Optionable Beta2.80 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Jon R. Levine (Age 59)Co-Founder, CEO, Interim CFO, President, Secretary, Treasurer & Director Comp: $390.5kMr. Timothy Shaw (Age 46)Chief Operating Officer Comp: $346.62kMr. Jonathan W. Rider (Age 59)Chief Information Officer Mr. Steve Wayne WestVice President of Investor RelationsMr. Howard SchacterChief Communications OfficerMr. Ryan CrandallChief Revenue OfficerMr. Charles Holt FinnieChief Strategy OfficerMore ExecutivesKey CompetitorsPrelude TherapeuticsNASDAQ:PRLDCartesian TherapeuticsNASDAQ:RNACPoseida TherapeuticsNASDAQ:PSTXElite PharmaceuticalsOTCMKTS:ELTPZura BioNASDAQ:ZURAView All Competitors MRMD Stock Analysis - Frequently Asked Questions How have MRMD shares performed this year? MariMed's stock was trading at $0.2748 on January 1st, 2024. Since then, MRMD stock has decreased by 40.7% and is now trading at $0.1629. View the best growth stocks for 2024 here. How were MariMed's earnings last quarter? MariMed Inc. (OTCMKTS:MRMD) posted its quarterly earnings results on Monday, November, 15th. The company reported $0.01 EPS for the quarter. The firm earned $33.21 million during the quarter. MariMed had a negative net margin of 10.97% and a negative trailing twelve-month return on equity of 2.75%. How do I buy shares of MariMed? Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of MariMed own? Based on aggregate information from My MarketBeat watchlists, some other companies that MariMed investors own include KushCo (KSHB), Organigram (OGI), Auxly Cannabis Group (CBWTF), CNBX Pharmaceuticals (CNBX), Supreme Cannabis (SPRWF), Pennsylvania Real Estate Investment Trust (PEI). This page (OTCMKTS:MRMD) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MariMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MariMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MRMD Stock Alerts